BMY
Bristol-Myers Squibb Company
Healthcare
$59.55
as of May 21, 2026
Sign in to add BMY to your portfolio.
Sign inMarket cap
$119.54B
P/E (TTM)
16.4x
EPS (TTM)
$3.56
Dividend yield
4.27%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $46.38B | $6.99B | $15.23B | 57.7% | 20.6% | $3.15 |
| 2022 | $46.16B | $6.33B | $11.95B | 57.4% | 20.1% | $2.97 |
| 2023 | $45.01B | $8.03B | $12.65B | 56.3% | 18.8% | $3.88 |
| 2024 | $48.30B | $-8.95B | $13.94B | 56.8% | 20.0% | $-4.41 |
| 2025 | $48.19B | $7.05B | $12.85B | 67.6% | 26.3% | $3.46 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $58.23 | $59.55 | 8.40M |
| May 20, 2026 | $58.67 | $58.54 | 8.55M |
| May 19, 2026 | $57.32 | $58.31 | 8.00M |
| May 18, 2026 | $57.45 | $57.31 | 11.56M |
| May 15, 2026 | $56.64 | $57.00 | 10.82M |
| May 14, 2026 | $56.69 | $56.77 | 7.69M |
| May 13, 2026 | $55.90 | $56.39 | 8.00M |
| May 12, 2026 | $56.01 | $56.45 | 9.27M |
| May 11, 2026 | $56.18 | $55.67 | 8.39M |
| May 08, 2026 | $56.33 | $56.16 | 10.03M |
| May 07, 2026 | $56.44 | $56.25 | 10.42M |
| May 06, 2026 | $57.23 | $56.54 | 10.44M |
| May 05, 2026 | $57.00 | $56.92 | 11.32M |
| May 04, 2026 | $57.65 | $57.38 | 9.45M |
| May 01, 2026 | $60.02 | $58.22 | 18.37M |
| Apr 30, 2026 | $57.69 | $60.59 | 24.88M |
| Apr 29, 2026 | $57.65 | $57.59 | 9.46M |
| Apr 28, 2026 | $58.58 | $58.26 | 6.27M |
| Apr 27, 2026 | $58.21 | $57.78 | 10.70M |
| Apr 24, 2026 | $58.86 | $58.71 | 6.82M |
| Apr 23, 2026 | $58.84 | $59.02 | 6.51M |
| Apr 22, 2026 | $59.40 | $58.80 | 7.50M |
| Apr 21, 2026 | $59.15 | $59.39 | 9.00M |
| Apr 20, 2026 | $60.00 | $59.13 | 7.68M |
Profitability & balance
- ROE (TTM)
- 39.1%
- Gross margin
- 68.8%
- Operating margin
- 25.7%
- Net margin
- 15.0%
- Debt / equity
- 2.22